{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:09:32Z","timestamp":1792249772926,"version":"4.4.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.beem.2009.05.005","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T22:02:29Z","timestamp":1259359349000},"page":"625-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Non-functioning pituitary adenomas"],"prefix":"10.1016","volume":"23","author":[{"given":"Yona","family":"Greenman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naftali","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2009.05.005_bib1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1210\/jcem-68-6-1128","article-title":"Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine","volume":"68","author":"Kwekkeboom","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2009.05.005_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas. A systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2009.05.005_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/eje.1.02107","article-title":"Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data","volume":"154","author":"Buurman","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/rep.0.1210363","article-title":"Pituitary tumors","volume":"121","author":"Davis","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.beem.2009.05.005_bib5","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Li\u00e8ge, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","article-title":"Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry","volume":"156","author":"Saeger","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","article-title":"A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas","volume":"61","author":"Yamada","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-005-1093-6","article-title":"The 2004 World Health Organization classification of pituitary tumors: what is new?","volume":"111","author":"Al-Shraim","year":"2006","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.beem.2009.05.005_bib9","first-page":"1128","article-title":"Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology","volume":"74","author":"Asa","year":"1992","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0092-8674(88)90038-4","article-title":"A tissue specific transcription factor containing a homeodomain specifies a pituitary phenotype","volume":"55","author":"Ingraham","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.beem.2009.05.005_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(01)00282-3","article-title":"A pituitary cell restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins","volume":"104","author":"Lamolet","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.beem.2009.05.005_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.5858\/2008-132-1231-PPPWDT","article-title":"Practical pituitary pathology. What does the pathologist need to know?","volume":"132","author":"Asa","year":"2008","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"10.1016\/j.beem.2009.05.005_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","article-title":"Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumors but do not recur more frequently","volume":"58","author":"Bradley","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem-66-6-1111","article-title":"A novel type of pituitary adenoma: morphological features and clinical correlations","volume":"66","author":"Horvath","year":"1988","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00701-003-0174-3","article-title":"Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas \u2013 a study on 721 patients","volume":"146","author":"Nomikos","year":"2004","journal-title":"Acta Neurochirurgica"},{"key":"10.1016\/j.beem.2009.05.005_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","article-title":"Early results of surgery in patients with nonfunctioning pituitary adenomas and analysis of the risk of tumor recurrence","volume":"108","author":"Losa","year":"2008","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3171\/JNS\/2008\/108\/4\/0736","article-title":"Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas","volume":"108","author":"Chang","year":"2008","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib18","first-page":"1789","article-title":"The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas","volume":"85","author":"Arafah","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2265.2003.01784.x","article-title":"Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth","volume":"58","author":"Greenman","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jocn.2006.07.016","article-title":"Cranial nerve palsies accompanying pituitary tumor","volume":"14","author":"Kim","year":"2007","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.beem.2009.05.005_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2265.2007.02759.x","article-title":"Macroprolactinomas and epilepsy","volume":"66","author":"Deepak","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/019459989110400316","article-title":"Spontaneous CSF rhinorrhea: an unusual presentation of a pituitary adenoma","volume":"104","author":"Carroll","year":"1991","journal-title":"Otolaryngology-Head and Neck Surgery"},{"key":"10.1016\/j.beem.2009.05.005_bib23","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2005-2552","article-title":"Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma","volume":"91","author":"Dekkers","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jcem-62-6-1173","article-title":"Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas","volume":"62","author":"Arafah","year":"1986","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib25","first-page":"1577","article-title":"Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas","volume":"80","author":"Greenman","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib26","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","article-title":"Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas","volume":"84","author":"Webb","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0025-6196(11)63002-4","article-title":"Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases","volume":"71","author":"Young","year":"1996","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.beem.2009.05.005_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.1.01854","article-title":"FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomas","volume":"152","author":"Hanson","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ncpendmet0758","article-title":"Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma","volume":"4","author":"Cooper","year":"2008","journal-title":"Nature Clinical Practice. Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/jcem-42-3-544","article-title":"Hypersecretion of LH and FSH by a pituitary adenoma","volume":"42","author":"Snyder","year":"1976","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2265.1989.tb01265.x","article-title":"Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone","volume":"31","author":"Heseltine","year":"1989","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib32","first-page":"167","article-title":"Sexual precocity in a boy due to hypersecretion of LH and prolactin by a pituitary adenoma","volume":"102","author":"Faggiano","year":"1983","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.beem.2009.05.005_bib33","first-page":"569","article-title":"Precocious puberty in a boy with a PRL-, LH- and FSH-secreting pituitary tumour: biosynthetic characterization and clinical studies","volume":"122","author":"Abrosi","year":"1990","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.beem.2009.05.005_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM199102283240904","article-title":"Recognition of gonadotroph adenomas in women","volume":"324","author":"Daneshdoost","year":"1991","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.05.005_bib35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2265.1997.1720986.x","article-title":"Combined \u03b2FSH and \u03b2LH response to TRH in patients with clinically non-functioning pituitary adenomas","volume":"46","author":"Somjen","year":"1997","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib36","first-page":"784","article-title":"A comparison between the diagnostic value of gonadotropins, \u03b1-subunits, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, \u03b1-subunit-secreting, and gonadotroph pituitary adenomas","volume":"77","author":"Nobels","year":"1993","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00701-007-1155-8","article-title":"Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests","volume":"149","author":"Yoshino","year":"2007","journal-title":"Acta Neurochirurgica"},{"key":"10.1016\/j.beem.2009.05.005_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0889-8529(05)70057-8","article-title":"Current approaches to imaging of the sellar region and pituitary","volume":"28","author":"Naidich","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2009.05.005_bib40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.crad.2007.10.003","article-title":"Imaging characteristics of common suprasellar lesions with emphasis on MRI findings","volume":"63","author":"Rao","year":"2008","journal-title":"Clinical Radiology"},{"key":"10.1016\/j.beem.2009.05.005_bib41","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1001\/jama.1990.03440200076026","article-title":"The \u201cincidentaloma\u201d of the pituitary gland. Is neurosurgery required?","volume":"263","author":"Reincke","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2009.05.005_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1995.00430020067008","article-title":"The natural history of pituitary incidentaloma","volume":"155","author":"Donovan","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2009.05.005_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1490123","article-title":"A survey of pituitary incidentaloma in Japan","volume":"149","author":"Sanno","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib44","first-page":"1344","article-title":"Therapeutic strategies for incidentally found pituitary tumors (\u201cPituitary Incidentalomas\u201d)","volume":"43","author":"Nishizawa","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2176\/nmc.39.592","article-title":"Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors \u2013 their natural history and surgical indications","volume":"39","author":"Igarashi","year":"1999","journal-title":"Neurologia Medico-Chirurgica (Tokyo)"},{"key":"10.1016\/j.beem.2009.05.005_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.1.02334","article-title":"The natural course of non-functioning pituitary macroadenomas","volume":"156","author":"Dekkers","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib47","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.2006.104.6.884","article-title":"Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination","volume":"104","author":"Arita","year":"2006","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2265.1999.00748.x","article-title":"Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas-results of a prospective study","volume":"51","author":"Feldkamp","year":"1999","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib49","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","article-title":"What is the natural history of nonoperated nonfunctioning pituitary adenomas?","volume":"67","author":"Karavitaki","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0090-3019(88)90138-3","article-title":"Management of large pituitary adenomas by transsphenoidal surgery","volume":"29","author":"Black","year":"1988","journal-title":"Surgical Neurology"},{"key":"10.1016\/j.beem.2009.05.005_bib51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/eje.1.02298","article-title":"Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors","volume":"155","author":"Ferrante","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0090-3019(99)00120-2","article-title":"Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery","volume":"52","author":"Zhang","year":"1999","journal-title":"Surgical Neurology"},{"key":"10.1016\/j.beem.2009.05.005_bib53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1227\/01.NEU.0000126885.71242.D7","article-title":"The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas","volume":"55","author":"Park","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00701-006-1044-6","article-title":"Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study","volume":"149","author":"Honneger","year":"2007","journal-title":"Acta Neurochirurgica (Wien)"},{"key":"10.1016\/j.beem.2009.05.005_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00006123-199702000-00001","article-title":"Complications of transsphenoidal surgery: results of a national survey, review of the literature and personal experience","volume":"40","author":"Ciric","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib56","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3171\/jns.2005.103.3.0448","article-title":"Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients","volume":"103","author":"Nemergut","year":"2005","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib58","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO;2-4","article-title":"The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas","volume":"68","author":"Comtois","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2009.05.005_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s007010200064","article-title":"Magnetic resonance imaging after transsphenoidal surgery of clinically nonfunctional pituitary macroadenomas and its impact on detecting residual adenoma","volume":"144","author":"Kremmer","year":"2002","journal-title":"Acta Neurochirurgica(Wien)"},{"key":"10.1016\/j.beem.2009.05.005_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.1999.00865.x","article-title":"Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation \u2013 a follow-up study","volume":"51","author":"Turner","year":"1999","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000095526","article-title":"Predictive markers of pituitary adenoma behavior","volume":"83","author":"Kontogeorgos","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","article-title":"Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody","volume":"38","author":"Thapar","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.52.2.107","article-title":"Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody","volume":"52","author":"Mastronardi","year":"1999","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.beem.2009.05.005_bib64","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3171\/jns.2003.99.4.0674","article-title":"Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness","volume":"99","author":"Honegger","year":"2003","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib65","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.humpath.2007.10.004","article-title":"Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas","volume":"38","author":"Gejman","year":"2008","journal-title":"Human Pathology"},{"key":"10.1016\/j.beem.2009.05.005_bib66","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00006123-200012000-00009","article-title":"Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long term follow-up studies","volume":"47","author":"Losa","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-07-0099","article-title":"Relevance of Ki-67 and prognostic factors for recurrence\/progression of gonadotropic adenomas after first surgery","volume":"157","author":"Dubois","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00393.x","article-title":"Radiotherapy for non-functioning pituitary tumours","volume":"48","author":"Gittoes","year":"1998","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib69","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1210\/jc.2002-020526","article-title":"Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors","volume":"87","author":"Erfurth","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenomas; update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism, West Midlands prospective hypopituitary study group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2009.05.005_bib72","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(92)90941-A","article-title":"Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors","volume":"30","author":"Tsang","year":"1994","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"Suppl. 5","key":"10.1016\/j.beem.2009.05.005_bib73","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3171\/jns.2002.97.supplement_5.0408","article-title":"Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma","volume":"97","author":"Sheehan","year":"2002","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11102-008-0089-3","article-title":"Radiotherapy of nonfunctioning and gonadotroph adenomas","volume":"12","author":"Kanner","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2009.05.005_bib75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10143-007-0072-x","article-title":"Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques","volume":"30","author":"Minniti","year":"2007","journal-title":"Neurosurgical Review"},{"key":"10.1016\/j.beem.2009.05.005_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.1986.tb03610.x","article-title":"Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine","volume":"25","author":"Bevan","year":"1986","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib77","first-page":"1368","article-title":"Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas","volume":"83","author":"Renner","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib78","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jc.2003-030859","article-title":"Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment","volume":"89","author":"Pivonello","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib79","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem-71-3-718","article-title":"Bromocriptine increasingly suppresses the in vitro gonadotropin and alpha-subunit release from pituitary adenomas during long term culture","volume":"71","author":"Kwekkeboom","year":"1990","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2265.1992.tb00953.x","article-title":"Lon-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or alpha-subunit secreting pituitary adenoma","volume":"36","author":"Kwekkeboom","year":"1992","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib81","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/ERC-07-0271","article-title":"Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study","volume":"15","author":"Florio","year":"2008","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.beem.2009.05.005_bib82","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/ERC-08-0181","article-title":"Medical therapy for clinically non-functioning pituitary adenomas","volume":"15","author":"Colao","year":"2008","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.beem.2009.05.005_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.2005.02295.x","article-title":"Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth","volume":"63","author":"Greenman","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.05.005_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-08-0213","article-title":"Cabergoline and the risk of valvular lesions in endocrine disease","volume":"159","author":"Lancellotti","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib86","first-page":"724","article-title":"Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage","volume":"79","author":"Greenman","year":"1994","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas","volume":"156","author":"Taboada","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib88","first-page":"179","article-title":"Effects of somatostatin-14 and the receptor specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from \u201cclinically nonfunctioning \u201dpituitary adenoma cells incubated in vitro","volume":"58","author":"Pawlikowski","year":"2007","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.beem.2009.05.005_bib89","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1530\/eje.0.1410396","article-title":"Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro","volume":"141","author":"Florio","year":"1999","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib90","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1210\/jc.2003-031954","article-title":"Evidence for differential effects of selective somatostatin receptor subtype agonists on \u03b1-subunit and chromogranin-A secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro","volume":"89","author":"Zatelli","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1677\/ERC-06-0026","article-title":"Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion","volume":"14","author":"Zatelli","year":"2007","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.beem.2009.05.005_bib92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.beem.2009.05.005_bib93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2265.2001.01172.x","article-title":"In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas","volume":"54","author":"Andersen","year":"2001","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib94","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1210\/jc.2006-0003","article-title":"Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma","volume":"91","author":"Dekkers","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.05.005_bib95","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas","volume":"69","author":"van der Klaauw","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib96","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2265.1997.1400957.x","article-title":"An account of the quality of life of patients after treatment for non-functioning pituitary tumours","volume":"46","author":"Page","year":"1997","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib97","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2007.01.017","article-title":"Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma","volume":"68","author":"van Beek","year":"2007","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1016\/j.beem.2009.05.005_bib98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2265.2006.02545.x","article-title":"Hypopituitarism and mortality in pituitary adenomas","volume":"65","author":"Lindholm","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11102-005-1757-1","article-title":"Retrospective multicentric study of pituitary incidentalomas","volume":"7","author":"Fainstein Day","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2009.05.005_bib100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00006123-199809000-00020","article-title":"Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas","volume":"43","author":"Lillehei","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2009.05.005_bib101","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2000.01153.x","article-title":"Nonfunctioning pituitary adenomas: indications for postoperative radiotherapy","volume":"53","author":"Woolons","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/eje.0.1460179","article-title":"MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas","volume":"146","author":"Soto-Ares","year":"2002","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.05.005_bib103","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2006.09.049","article-title":"Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy","volume":"67","author":"van den Bergh","year":"2007","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1016\/j.beem.2009.05.005_bib104","unstructured":"O'Sullivan EP, Woods C, Glynn N, et-al. The natural history of surgically treated but radiotherapy na\u00efve non-functioning pituitary adenomas. Clinical Endocrinology. doi:10.1111\/j1365\u20132265.2009.03583.x."}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X09000517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X09000517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:41:01Z","timestamp":1761496861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X09000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1521690X09000517"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2009.05.005","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-functioning pituitary adenomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2009.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}